共 50 条
- [31] Comparison of Real-World Healthcare Resource Utilization Among Advanced Therapy-Experienced Patients With Ulcerative Colitis Initiated on Ustekinumab or Vedolizumab AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (12S): : S15 - S15
- [34] Real World Experience With Vedolizumab as First-Line Therapy for the Treatment of Ulcerative Colitis AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S439 - S439
- [36] Real-world characteristics and complications of patients with Ulcerative Colitis receiving conventional therapy in the public healthcare system in Brazil JOURNAL OF CROHNS & COLITIS, 2022, 16 : I443 - I443
- [37] Real-world characteristics and complications of patients with Ulcerative Colitis receiving conventional therapy in the public healthcare system in Brazil JOURNAL OF CROHNS & COLITIS, 2022, 16 : I443 - I443
- [38] Commentary on the real-world effectiveness of vedolizumab in therapy-experienced ulcerative colitis: A response to Azzam et al. SAUDI JOURNAL OF GASTROENTEROLOGY, 2025, 31 (02): : 100 - 101